Missing/wrong data?
Log in to edit
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
scientific article published on 3 February 2016
Author/s
author: Andreas Hochhaus, Giuseppe Saglio, Richard A. Larson, Timothy Hughes
Work details
Publication date
February 3, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.